Corpus 1,280 assessed · 1,181 scored · 646 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 4 Datasets 392.5k Experiments 5.2k

Explore

Filters: US ✕ 2026 ✕ 0 ✕ clear all

4 matching publication(s)

Publication	Journal	Year	Score	Verdict
Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells. PMID 41933175	Nature metabolism	2026	48	L1 48/100
CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis. ⚑ PMID 42180553	Acta Pharm Sin B	2026	29	L1 29/100 ⚑
FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma. ⚑ PMID 41789627	Int J Oncol	2026	10	10/100 ⚑
MUTACLASH: identifying functional small RNA target sites using crosslinking-induced mutations. PMID 41330639	RNA	2026	30	L1 30/100

Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.

PMID 41933175 · Nature metabolism · 2026

L1 48/100

CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis.⚑

PMID 42180553 · Acta Pharm Sin B · 2026

L1 29/100 ⚑

FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma.⚑

PMID 41789627 · Int J Oncol · 2026

10/100 ⚑

MUTACLASH: identifying functional small RNA target sites using crosslinking-induced mutations.

PMID 41330639 · RNA · 2026

L1 30/100